Amanote Research

Amanote Research

    RegisterSign In

Liver Safety Assessment in Special Populations (Hepatitis B, C, and Oncology Trials)

Drug Safety - United Kingdom
doi 10.1007/s40264-014-0186-3
Full Text
Open PDF
Abstract

Available in full text

Categories
ToxicologyPharmacology
Date

October 29, 2014

Authors
Gerd A. Kullak-UblickMichael MerzLouis GriffelNeil KaplowitzPaul B. Watkins
Publisher

Springer Science and Business Media LLC


Related search

Treatment of Hepatitis C in Special Populations

Journal of Gastroenterology
Gastroenterology
2018English

Management of Chronic Hepatitis B in Special Populations

Medical Journal of Viral Hepatitis
2020English

Non-Invasive Assessment of Liver Fibrosis Through FibroMeter in Patients With Chronic Viral Hepatitis B and C

BMC Infectious Diseases
Infectious Diseases
2014English

Shear Wave Elastography; Assessment of Liver Fibrosis in a Patient of Chronic Liver Disease Associated Infected by Hepatitis B and C

The Professional Medical Journal
2016English

Quantitative Imaging Assessment for Clinical Trials in Oncology

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2019English

Hepatitis C and Liver Transplantation

2012English

Hepatitis B and C in Dentistry

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2009English

Hepatitis B and C Viruses

2019English

Serum Markers for Assessing Liver Fibrosis in Egyptian Patients With Chronic Hepatitis B and C Co-Infection Versus Chronic Hepatitis C

Journal of the Egyptian Society of Parasitology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy